Buscar | Ifvex

Ifvex

agregó una foto Health
2025-05-27 09:13:31 -

Hong Kong’s PHASE Scientific raises $34M Series A round to advance urine-based diagnostic technology for early disease detection
PHASE Scientific International Limited, a Hong Kong-based biotechnology company, announced Tuesday the successful completion of a $34 million Series A funding round. The firm said in a statement that this represents the largest Series A raise in Asia’s diagnostic technology sector since 2019, reflecting robust investor conviction in PHASE Scientific’s innovative PHASIFY™...

0 Commentarios 0 Acciones 6K Views 0 Vista previa

Please log in to like, share and comment!
Ifvex

agregó una foto Health
2025-02-12 04:27:14 -

Life Science Incubator unveils Singapore’s largest co-working laboratory at Elementum
Life Science Incubator (LSI) has officially launched the largest co-working laboratory in Singapore at Elementum, located in JTC’s one-north business park. This launch further strengthens Singapore’s prominence as a premier life sciences hub in Asia Pacific, LSI said in a statement on Monday. As Singapore continues to be a preferred destination for biotech, MedTech, and...

0 Commentarios 0 Acciones 8K Views 0 Vista previa

Please log in to like, share and comment!
Ifvex

agregó una foto Health
2025-05-25 11:33:56 -

Malaysia’s Betamek partners Singapore’s SiGenex for AI genomics diagnostic and sequencing solution
Betamek Berhad, a Malaysia-based original design manufacturer (ODM), has partnered with SiGenex Global Holdings Pte. Ltd. (SiGenex), a Singapore-based technology firm, for artificial intelligence (AI) genomics diagnostic and sequencing solution. Betamek said in a statement that the firm, through its wholly-owned subsidiary Betamek Research Sdn. Bhd. (BRSB) has entered into a memorandum of...

0 Commentarios 0 Acciones 7K Views 0 Vista previa

Please log in to like, share and comment!
Ifvex

agregó una foto Health
2025-05-09 14:00:50 -

Singapore’s Nuevocor raises $45M Series B for Novel Cardiomyopathy therapy development
Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, has announced the successful completion of $45 million Series B financing. The round was co-led by Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio and Boehringer Ingelheim Venture Fund,...

0 Commentarios 0 Acciones 5K Views 0 Vista previa

Please log in to like, share and comment!
Ifvex

agregó una foto Health
2025-06-09 05:04:15 -

Temasek’s ClavystBio, Lightstone Ventures back Allay Therapeutics’ $57.5M Series D financing
Allay Therapeutics, a clinical-stage biotechnology company, announced last Thursday the completion of a $57.5 million Series D financing round with leading global investors. The firm said in a statement that Lightstone Ventures and Temasek-backed ClavystBio co-led the Series D financing with participation by existing investors NEA, Arboretum Ventures, Vertex Growth, Vertex Ventures Healthcare,...

0 Commentarios 0 Acciones 3K Views 0 Vista previa

Please log in to like, share and comment!
Ifvex

agregó una foto Food
2025-05-20 11:40:45 -

Thailand’s MUU secures strategic investment from A2D Ventures, Leave a Nest Japan and a Japanese food conglomerate
MUU, Thailand’s first animal-free dairy biotech startup, has secured strategic investment from A2D Ventures, Leave a Nest Japan, and another leading Japanese food conglomerate. This funding will accelerate MUU’s mission to transform the dairy industry through precision fermentation, offering sustainable, ethical, and healthier dairy alternatives forSoutheast Asia and beyond, MUU...

0 Commentarios 0 Acciones 5K Views 0 Vista previa

Please log in to like, share and comment!